Immatics (IMTX) Cash & Equivalents (2019 - 2025)

Immatics recorded quarterly Cash & Equivalents of $275.6 million in Q4 2025, little changed quarter-over-quarter from $276.8 million in Q3 2025, and up 18.04% year-over-year from $233.5 million in Q4 2024.

Immatics' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $275.6 million for Q4 2025.

  • In Q4 2025, Cash & Equivalents rose 18.04% year-over-year to $275.6 million; the TTM figure through Dec 2025 stood at $275.6 million (up 18.04% YoY), while the FY2025 annual figure was $267.5 million, up 14.57% from the prior year.
  • Cash & Equivalents came in at $275.6 million for Q4 2025 at Immatics, roughly flat from $276.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $290.5 million in Q2 2025 to a low of $134.1 million in Q3 2022.
  • A 5-year average of $211.5 million and a median of $235.2 million in 2024 frame the typical range for Cash & Equivalents.
  • Across the five-year window, Cash & Equivalents jumped 119.54% in 2021 and plunged 45.21% in 2022, its largest moves.
  • Immatics' Cash & Equivalents stood at $152.1 million in 2021, then retreated by 0.4% to $151.5 million in 2022, then jumped by 55.13% to $235.1 million in 2023, then fell by 0.68% to $233.5 million in 2024, then advanced by 18.04% to $275.6 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $275.6 million, $276.8 million, and $290.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 1.91 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 32.30 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 61.46 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.71 Bn
10 Immatics 1.80 Bn 1.80 Bn - 275.58 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 275.58 Mn
Sep 30, 2025 276.77 Mn
Jun 30, 2025 290.50 Mn
Mar 31, 2025 249.03 Mn
Dec 31, 2024 233.46 Mn
Sep 30, 2024 239.93 Mn
Jun 30, 2024 235.27 Mn
Mar 31, 2024 237.34 Mn
Dec 31, 2023 235.06 Mn
Sep 30, 2023 161.68 Mn
Jun 30, 2023 161.73 Mn
Mar 31, 2023 159.41 Mn
Dec 31, 2022 151.53 Mn
Sep 30, 2022 134.09 Mn
Jun 30, 2022 141.91 Mn
Mar 31, 2022 149.26 Mn
Dec 31, 2021 152.14 Mn
Sep 30, 2021 244.74 Mn
Jun 30, 2021 249.92 Mn
Mar 31, 2021 250.33 Mn
Dec 31, 2020 247.44 Mn
Sep 30, 2020 120.72 Mn
Jun 30, 2020 113.84 Mn
Mar 31, 2020 114.10 Mn
Dec 31, 2019 114.40 Mn
Sep 30, 2019 43.80 Mn
Jun 30, 2019 44.23 Mn